As China sees a rise in birth rates, a genetic screening processor and neonatal reagent kit delivers advanced capabilities to newborn screening labs for detecting life-threatening conditions.
Read More
Using the expression levels of 10 miRNAs, the test achieves a negative predictive value of 94% and positive predictive value of 74% at a cancer prevalence of 32%.
Read MoreStudies led by Mayo Clinic investigators combine common genetic variants and other factors to improve personalized estimates of breast cancer risk.
Read More
In clinical labs, the application of modern lab informatics systems covers a growing range of uses.
Read More
CLP spoke with Roger D. Klein, MD, JD, FCAP, medical director for molecular oncology at the Cleveland Clinic, and chair of the Association for Molecular Pathology’s professional relations committee, to find out more about AMP’s revised policy on direct-to-consumer genetic testing.
Read More